Markus R Meyer - JoVE Visualize

Showing results (61-70 of 261) with videos related to

Pageof 27

Sort By:

Archives of Toxicology|April 22, 2020

Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adductsSascha K Manier, Lea Wagmann, Veit Flockerzi, et al.

Journal of Analytical Toxicology|September 8, 2022

Clinical Toxicological Follow-Up Analysis of a Suicide Attempt Using ChloroquineCathy M Jacobs, Lea Wagmann, Fabian Frankenfeld, et al.

Drug Testing and Analysis|July 6, 2017

Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometryMadeleine Pettersson Bergstrand, Markus R Meyer, Olof Beck, et al.

Drug Testing and Analysis|November 28, 2023

Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methodsFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.

Molecules (Basel, Switzerland)|October 2, 2020

Drug Administration Routes Impact the Metabolism of a Synthetic Cannabinoid in the Zebrafish Larvae ModelYu Mi Park, Markus R Meyer, Rolf Müller, et al.

Therapeutic Drug Monitoring|November 16, 2013

Application of a UHPLC MS/MS-based multianalyte approach for screening and validated quantification of drugs in human blood plasma often requested in the context of brain death diagnosisDaniela Remane, Deborah Montenarh, Markus R Meyer, et al.

Drug Testing and Analysis|August 31, 2018

Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometryLilian H J Richter, Hans H Maurer, Markus R Meyer

Journal of Mass Spectrometry : JMS|October 13, 2015

Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP)Markus R Meyer, Anna Holderbaum, Pierce Kavanagh, et al.

Analytica Chimica Acta|April 15, 2014

Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry/mass spectrometry and studies on their glutathionyl transferase inhibition potencyMarkus R Meyer, Lilian H J Richter, Hans H Maurer

Analytical and Bioanalytical Chemistry|January 24, 2014

Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSnJessica Welter, Markus R Meyer, Pierce Kavanagh, et al.

Pageof 27

Showing results (61-70 of 261) with videos related to

Sort By:

Pageof 27

Archives of Toxicology|April 22, 2020

Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adductsSascha K Manier, Lea Wagmann, Veit Flockerzi, et al.

Journal of Analytical Toxicology|September 8, 2022

Clinical Toxicological Follow-Up Analysis of a Suicide Attempt Using ChloroquineCathy M Jacobs, Lea Wagmann, Fabian Frankenfeld, et al.

Drug Testing and Analysis|July 6, 2017

Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometryMadeleine Pettersson Bergstrand, Markus R Meyer, Olof Beck, et al.

Drug Testing and Analysis|November 28, 2023

Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methodsFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.

Molecules (Basel, Switzerland)|October 2, 2020

Drug Administration Routes Impact the Metabolism of a Synthetic Cannabinoid in the Zebrafish Larvae ModelYu Mi Park, Markus R Meyer, Rolf Müller, et al.

Therapeutic Drug Monitoring|November 16, 2013

Application of a UHPLC MS/MS-based multianalyte approach for screening and validated quantification of drugs in human blood plasma often requested in the context of brain death diagnosisDaniela Remane, Deborah Montenarh, Markus R Meyer, et al.

Drug Testing and Analysis|August 31, 2018

Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometryLilian H J Richter, Hans H Maurer, Markus R Meyer

Journal of Mass Spectrometry : JMS|October 13, 2015

Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP)Markus R Meyer, Anna Holderbaum, Pierce Kavanagh, et al.

Analytica Chimica Acta|April 15, 2014

Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry/mass spectrometry and studies on their glutathionyl transferase inhibition potencyMarkus R Meyer, Lilian H J Richter, Hans H Maurer

Analytical and Bioanalytical Chemistry|January 24, 2014

Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSnJessica Welter, Markus R Meyer, Pierce Kavanagh, et al.

Pageof 27